Ke ulu nei ka noi ʻana o ka microbiology ʻoihana i loko o ka lāʻau lapaʻau a me ka ʻoihana meaʻai a me nā mea inu ma waena o Kina, US, Kelemānia a me India e hoʻoikaika i ka koi o ka microbiology ʻenehana ma ka honua holoʻokoʻa.
Ke ulu nei ka hoʻohana ʻana i ka sterility a me ka hoʻāʻo ʻana i ka bio-burden i loko o ka ʻoihana lāʻau lapaʻau e hoʻoulu i ke kūʻai aku o nā huahana microbiology ʻenehana.
ʻO ka hoʻonui ʻana i nā hana noiʻi a me ka hoʻomohala ʻana me ka ulu ʻana o ka lāʻau lapaʻau i loko o ka ʻoihana biopharmaceutical ma waena o US, Farani, a me India e hoʻoikaika i ka ulu ʻana o ka mākeke i nā makahiki e hiki mai ana.
ʻO ka hoʻonui ʻana i nā noi i nā mea hoʻohana lāʻau lapaʻau ua paipai i ka hoʻopaʻa ʻana i ka sterility a me ka hoʻāʻo bio-burden no ka hoʻāʻo ʻana i ka maikaʻi o nā lāʻau lapaʻau a me nā micro-organisms. Eia nō naʻe, ʻo ka nele o nā limahana akamai a me nā kumu kūʻai kiʻekiʻe e hoʻopilikia i ka ulu ʻana o ka microbiology ʻenehana.
Ma muli o ka laha ʻole o COVID-19, ua hōʻole ʻia ke kūʻai ʻana o ka microbiology ʻenehana 1.95%, e hōʻike ana i kahi CAGR ma 4.95% i ka wā wānana.
Eia nō naʻe, me ka piʻi ʻana o nā hana e hōʻemi i ka pollution a hoʻomaikaʻi i ka maikaʻi o ka mālama ʻana i ka wai, e hōʻea ka loiloi mākeke microbiology ʻoihana. US $ 21,566.24 Mn i ka makahiki 2031.
No ka noho ʻana ma mua o kāu mau mea hoʻokūkū, e noi i kahi laʻana - https://www.futuremarketinsights.com/reports/sample/rep-gb-1743
ʻO nā mea nui e lawe ʻia mai ka FMI's Industrial Microbiology Market Study
- Manaʻo ʻia ka ʻoihana lāʻau lapaʻau e lilo i mea hoʻohana hope loa o ka mākeke microbiology ʻoihana
- ʻO ka hoʻāʻo ʻana ʻo Sterility ka ʻano hoʻāʻo maikaʻi loa ma waena o nā mea pāʻani koʻikoʻi i kākoʻo ʻia e ka hoʻonui ʻia ʻana o ka noi ma ka ʻoihana lāʻau lapaʻau.
- ʻO ka hoʻonui ʻana i ka noi ʻana o ka microbiology ʻenehana i ka meaʻai a me nā mea inu e manaʻo ʻia e hoʻoulu i ke kūʻai aku, ʻoi aku ma waena o US a me India.
- I ka ʻōlelo o ka huahana, manaʻo ʻia nā mea hoʻopau hopena e alakaʻi i ka ʻāpana i ka wā wānana
- Manaʻo ʻia ʻo India e kū mai ma ke ʻano he mākeke waiwai no ka hoʻonui ʻana o ka ʻoihana mālama olakino a me ka ulu ʻana o ka noi i ka ʻoihana lāʻau lapaʻau.
- Manaʻo ʻia ʻo Kelemania ka ʻāina ʻoi loa ka loaʻa kālā, ʻoi aku ka nui 31% o ka mahele makeke honua
- Manaʻo ʻia ʻo Kina e alakaʻi i ka mākeke o Asia Hikina i ka wā wānana, e hoʻopaʻa inoa ana i kahi ulu stellar i ka wā loiloi.
- Ua manaʻo ʻia ʻo US ka mākeke nui loa no ka mākeke microbiology ʻoihana i pili i ka ulu ʻana o nā mea kūʻai aku a me ka piʻi ʻana o ka hoʻāʻo ʻana o ka sterility i ka ʻoihana lāʻau.
"Ke hoʻonui nei nā mea pāʻani koʻikoʻi i nā hana noiʻi a me ka hoʻomohala ʻana e hoʻomaʻamaʻa i ka ʻike ʻana i ka lāʻau lapaʻau a me ka hoʻāʻo ʻana i ka meaʻai i loko o ka lāʻau lapaʻau & ʻoihana meaʻai. ʻO kēia ka mea e hoʻonui i nā manawa ulu no nā mea pāʻani mākeke i nā makahiki e hiki mai ana, "wahi a ka mea loiloi FMI.
Palapala Kūleʻa
ʻO ka Future Market Insights, i kāna hōʻike hou, ua hōʻike i nā mea pāʻani koʻikoʻi e hana ana i ka mākeke microbiology ʻenehana e komo pū ana.
- Thermo Fisher ʻ Scientlelo Inc.
- ʻO Bio-Rad Laboratories Inc.
- ʻO Becton
- Dickinson a me ka Hui
- Ahahui Asiagel
- Eppendorf AG
- bioMérieux SA
- Novamed.
- QIAGEN
- Sartorius AG
- 3M
- ʻO Merck KGaA a me Danaher Corporation ma waena o nā mea ʻē aʻe.
Ke hoʻomau nei nā mea hana o nā ʻōnaehana microbiology ʻenehana i ka hoʻonui ʻana i kā lākou waihona huahana e hoʻomaikaʻi i kā lākou loaʻa kālā.
E like me ka FMI, ua hoʻomalu ʻia ka mākeke e nā mea pāʻani kiʻekiʻe e like me Thermo Fisher Scientific Inc. a me BioMerieuxx Inc. e hoʻohui nei i ka mākeke.
ʻO ka hui pū ʻana a me ka hui pū ʻana me nā ʻoihana olakino a me nā ʻoihana lāʻau lapaʻau i manaʻo ʻia ʻo ia ke kumu nui e mālama ai i ko lākou kūlana kiʻekiʻe ma ka ʻoihana.
ʻO ka hoʻomaka ʻana o nā huahana hou me ka hoʻonui ʻana o kā lākou huahana i kēia manawa kekahi o ka hoʻolālā mākeke maʻamau no nā mea pāʻani koʻikoʻi. ʻo kahi laʻana:
Ma Malaki 2020, hoʻolaha ka mea hoʻokani pila, Danaher Corporation i ka loaʻa ʻana o ka ʻoihana biopharma mai ka Life Science Division o General Electronics. Me kēia loaʻa, ua kapa hou ʻia ka hui ʻo Cytiva a e hana ʻo ia ma ke ʻano he ʻoihana kūʻokoʻa i loko o ka Danaher Corporation.
Nā ʻike hou aku e pili ana i ka Global Industrial Microbiology Market
ʻO ka Future Market Insights, i kāna hōʻike hou loa, hāʻawi i kahi uhi hohonu i ka mākeke microbiology ʻoihana honua, e hāʻawi ana i ka ʻikepili mōʻaukala no ka manawa o 2016-2020 a me nā helu wānana no ka manawa o 2021-2031. I mea e hoʻomaopopo ai i ka hiki o ka mākeke honua, kona ulu ʻana, a me ka laulā, ua hoʻokaʻawale ʻia ka mākeke ma ke kumu o ke ʻano o nā huahana (nā lako a me nā ʻōnaehana, nā mea hoʻopau hopena, a me nā mea ʻē aʻe), ʻano hoʻāʻo (sterility testing, microbial limits testing, a me bio- ka ho'āʻo kaumaha), a me ka mea hoʻohana hope (lāʻau lapaʻau & biotechnology, meaʻai a me nā mea inu, mahiʻai a me ke kaiapuni, a me nā huahana mālama pilikino) ma ʻehiku mau ʻāpana nui (ʻAmelika ʻĀkau, ʻAmelika ʻAmelika, ʻEulopa Hikina, ʻAsia Pākīpika me ka ʻole o Iapana, Western Europe, Iapana a me Waena. Hikina & ʻApelika)
